oxycodone has been researched along with Neoplasm Metastasis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harada, Y; Jinno, H; Kitagawa, Y; Kitasato, K; Murai, S; Oto, I; Shimizu, H; Yabe, N; Yokoe, T; Yokose, T; Yoshikawa, T | 1 |
| Fujii, S; Ikeda, M; Koike, Y; Kubo, S; Kurebayashi, J; Mizutou, A; Nakashima, K; Nomura, T; Oota, Y; Saitou, W; Seki, M; Shiiki, S; Shimo, T; Sonoo, H; Tanaka, K; Yamamoto, Y; Yamashita, T | 1 |
1 trial(s) available for oxycodone and Neoplasm Metastasis
| Article | Year |
|---|---|
[A pilot study of the reduced effects of adverse events caused by oral morphine and oxycodone after rotating to fentanyl patch in patients with metastatic breast cancer].
Topics: Administration, Cutaneous; Administration, Oral; Adult; Aged; Breast Neoplasms; Drug Therapy, Combination; Female; Fentanyl; Humans; Middle Aged; Morphine; Neoplasm Metastasis; Oxycodone; Pain; Pilot Projects; Prospective Studies; Transdermal Patch | 2012 |
1 other study(ies) available for oxycodone and Neoplasm Metastasis
| Article | Year |
|---|---|
[A Case of Advanced Breast Cancer in Which Marked Improvement of Joint Pain Was Obtained with Stepwise Dose Reduction of Trastuzumab Emtansine (T-DM1)].
Topics: Ado-Trastuzumab Emtansine; Antibodies, Monoclonal, Humanized; Arthralgia; Breast Neoplasms; Female; Humans; Maytansine; Middle Aged; Neoplasm Metastasis; Oxycodone; Trastuzumab | 2015 |